Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mitsuya

Showing results (91-100 of 343) with videos related to

Pageof 35
Sort By:
Antiviral Research|September 1, 1995
In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddIS Chokekijchai, T Shirasaka, J N Weinstein, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Treatment of acquired immunodeficiency syndromeR Yarchoan, J M Pluda, H Mitsuya, et al.
Immunology Today|June 1, 1996
HIV-I infection and cellular metabolismC De Simone, G Famularo, G Cifone, et al.
Annals of Internal Medicine|October 15, 1990
NIH conference. Antiretroviral therapy in AIDSS Broder, H Mitsuya, R Yarchoan, et al.
International Journal of Cancer|March 15, 1986
Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)J Balzarini, H Mitsuya, E De Clercq, et al.
Biochemical and Biophysical Research Communications|April 14, 1986
Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virusJ Balzarini, H Mitsuya, E De Clercq, et al.
Antiviral Research|February 26, 1998
HIV-1 acquires resistance to two classes of antiviral drugs through homologous recombinationK Yusa, M F Kavlick, P Kosalaraksa, et al.
Cancer Research|September 1, 1985
Pharmacological inhibition of infectivity of HTLV-III in vitroH Mitsuya, S Matsushita, M E Harper, et al.
Urologia Internationalis|January 1, 1976
Crossed ectopia of solitary kidney. A report of two cases and a review of the literatureH Kakei, A Kondo, B I Ogisu, et al.
The Journal of Clinical Investigation|September 1, 1991
Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vectorT Shimada, H Fujii, H Mitsuya, et al.
Pageof 35

Showing results (91-100 of 343) with videos related to

Sort By:
Pageof 35
Antiviral Research|September 1, 1995
In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddIS Chokekijchai, T Shirasaka, J N Weinstein, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Treatment of acquired immunodeficiency syndromeR Yarchoan, J M Pluda, H Mitsuya, et al.
Immunology Today|June 1, 1996
HIV-I infection and cellular metabolismC De Simone, G Famularo, G Cifone, et al.
Annals of Internal Medicine|October 15, 1990
NIH conference. Antiretroviral therapy in AIDSS Broder, H Mitsuya, R Yarchoan, et al.
International Journal of Cancer|March 15, 1986
Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)J Balzarini, H Mitsuya, E De Clercq, et al.
Biochemical and Biophysical Research Communications|April 14, 1986
Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virusJ Balzarini, H Mitsuya, E De Clercq, et al.
Antiviral Research|February 26, 1998
HIV-1 acquires resistance to two classes of antiviral drugs through homologous recombinationK Yusa, M F Kavlick, P Kosalaraksa, et al.
Cancer Research|September 1, 1985
Pharmacological inhibition of infectivity of HTLV-III in vitroH Mitsuya, S Matsushita, M E Harper, et al.
Urologia Internationalis|January 1, 1976
Crossed ectopia of solitary kidney. A report of two cases and a review of the literatureH Kakei, A Kondo, B I Ogisu, et al.
The Journal of Clinical Investigation|September 1, 1991
Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vectorT Shimada, H Fujii, H Mitsuya, et al.
Pageof 35